TOMASETTI, CARMINE
 Distribuzione geografica
Continente #
AS - Asia 2.179
NA - Nord America 2.161
EU - Europa 1.276
SA - Sud America 342
AF - Africa 72
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.037
Nazione #
US - Stati Uniti d'America 2.079
SG - Singapore 946
RU - Federazione Russa 649
VN - Vietnam 462
CN - Cina 421
BR - Brasile 287
IT - Italia 203
HK - Hong Kong 146
DE - Germania 97
FR - Francia 72
FI - Finlandia 54
CA - Canada 50
IE - Irlanda 47
GB - Regno Unito 37
JP - Giappone 33
NL - Olanda 32
CI - Costa d'Avorio 30
BD - Bangladesh 26
AR - Argentina 23
SE - Svezia 22
IN - India 19
MX - Messico 18
ID - Indonesia 17
KR - Corea 15
ZA - Sudafrica 15
PK - Pakistan 14
TH - Thailandia 13
UA - Ucraina 11
ES - Italia 10
IQ - Iraq 10
PH - Filippine 10
PL - Polonia 10
TW - Taiwan 10
AT - Austria 8
TR - Turchia 7
CL - Cile 6
EC - Ecuador 6
VE - Venezuela 6
CO - Colombia 5
KE - Kenya 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
DZ - Algeria 4
EG - Egitto 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
AL - Albania 3
AU - Australia 3
LT - Lituania 3
MA - Marocco 3
NP - Nepal 3
OM - Oman 3
BW - Botswana 2
BY - Bielorussia 2
CD - Congo 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
GY - Guiana 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NI - Nicaragua 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
TN - Tunisia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CU - Cuba 1
CZ - Repubblica Ceca 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
LB - Libano 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
NC - Nuova Caledonia 1
NE - Niger 1
PA - Panama 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
VI - Stati Uniti Isole Vergini 1
YE - Yemen 1
Totale 6.037
Città #
San Jose 497
Singapore 445
Chandler 166
Beijing 163
Ashburn 156
Moscow 153
Hong Kong 140
Santa Clara 122
Ho Chi Minh City 109
Hanoi 99
Millbury 60
The Dalles 47
Lauterbourg 46
Los Angeles 45
Dong Ket 42
Princeton 41
Nanjing 36
Des Moines 32
New York 30
Napoli 28
São Paulo 28
Hefei 27
Haiphong 26
Munich 26
Tokyo 26
Dallas 25
Redondo Beach 24
Buffalo 22
Norwalk 22
Amsterdam 21
Seattle 20
Ottawa 19
Wilmington 18
Da Nang 17
Frankfurt am Main 15
Nuremberg 15
Boston 14
Council Bluffs 14
Falkenstein 13
Helsinki 13
Montreal 12
Naples 12
Lawrence 11
San Francisco 11
Turku 11
Denver 10
Jacksonville 10
Mexico City 10
Orem 10
Rio de Janeiro 10
Shenyang 10
Brooklyn 9
Dhaka 9
Milan 9
Nanchang 9
Phoenix 9
Atlanta 8
Charlotte 8
Chicago 8
Changsha 7
Jiaxing 7
Johannesburg 7
Porto Alegre 7
Redwood City 7
Rome 7
Bangkok 6
Belo Horizonte 6
Can Tho 6
Houston 6
Ortona 6
Toronto 6
Warsaw 6
Woodbridge 6
Baghdad 5
Brasília 5
Caxias do Sul 5
Curitiba 5
Hebei 5
Karachi 5
Montevideo 5
Nairobi 5
Seoul 5
Thái Nguyên 5
Biên Hòa 4
Calgary 4
Cincinnati 4
Dublin 4
Gallipoli 4
Hải Dương 4
Miami 4
Ninh Bình 4
Phủ Lý 4
Poplar 4
Salvador 4
Tamworth 4
Tianjin 4
Torino 4
Vĩnh Long 4
Boardman 3
Bình Phước 3
Totale 3.254
Nome #
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study 219
D-aspartate dysregulation in Ddo-/- mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum 202
Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine 172
Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling 146
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 143
Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia 140
Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance 136
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones 133
Switching antipsychotics: Imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats 130
The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes 127
May second generation long-acting injectable antipsychotics be prescribed as a first-line treatment of first episode in patients with schizophrenia? An overview. 125
Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor 124
New advances in the treatment of generalized anxiety disorder: The multimodal antidepressant vortioxetine 124
Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action 123
Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment 123
Alexithymia, resilience, somatic sensations and their relationships with suicide ideation in drug naïve patients with first-episode major depression: An exploratory study in the “real world” everyday clinical practice 123
Modulation of glutamatergic functional connectivity by a prototypical antipsychotic: Translational inference from a postsynaptic density immediate-early gene-based network analysis 122
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies beyond Dopamine Receptor Antagonism 122
Immediate-early genes modulation by antipsychotics: Translational implications for a putative gateway to drug-induced long-term brain changes 122
MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective 120
A Postsynaptic Density Immediate Early Gene-Based Connectome Analysis of Acute NMDAR Blockade and Reversal Effect of Antipsychotic Administration 120
The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions 119
Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins 115
Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. 114
Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). 113
Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches. 113
When Clozapine Fails: Augmentation Strategies in the Management of Clozapine-Resistant Schizophrenia 113
The Homer1 family of proteins at the crossroad of dopamine-glutamate signaling: An emerging molecular “Lego” in the pathophysiology of psychiatric disorders. A systematic review and translational insight 112
Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions 110
Sensation seeking in major depressive patients: relationship to sub-threshold bipolarity and cyclothymic temperament 110
Eradicating suicide at its roots: Preclinical bases and clinical evidence of the efficacy of ketamine in the treatment of suicidal behaviors 110
Scaffolding Proteins of the Post-synaptic Density Contribute to Synaptic Plasticity by Regulating Receptor Localization and Distribution: Relevance for Neuropsychiatric Diseases 109
Differential Adaptive Changes in Dopaminergic System by Acute vs. Subchronic Ketamine: Relevance for Psychosis Pathophysiology and Treatment 109
Prevalence and clinical features associated to bipolar disorder-migraine comorbidity: A systematic review 99
Alexithymia, suicide ideation, affective temperaments and homocysteine levels in drug naïve patients with post-traumatic stress disorder: an exploratory study in the everyday ‘real world’ clinical practice 97
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression 96
An update of safety of clinically used atypical antipsychotics 96
Novel pathways in the treatment of major depression: Focus on the glutamatergic system 91
Suicide during perinatal period: Epidemiology, risk factors, and clinical correlates 86
Alexithymia, responsibility attitudes and suicide ideation among outpatients with obsessive-compulsive disorder: An exploratory study 85
The role of melatonin in mood disorders 85
“Resistenza alla gestione farmacologica della depressione bipolare resistente: Refrattarietà vs. tolleranza a litio in pazienti precedentemente responsivi. Inquadramento clinico, cenni neurobiologici, e prospettive terapeutiche.” – Evento: “Unveiling the dark side of the mood: nuove prospettive diagnostiche e terapeutiche per il trattamento dei disturbi depressivi”. Giulianova (Teramo), 6 Ottobre 2016. 81
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in “real-world,” everyday clinical practice 80
Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine 79
An Update on Glutamatergic System in Suicidal Depression and on the role of Esketamine 76
The Problem of Eating Disorders and Comorbid Psychostimulants Abuse - A Mini Review 74
The role of intranasal oxytocin in the treatment of patients with schizophrenia: a systematic review 74
Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials 74
Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment 73
The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice 72
The ‘dead man walking’ disorder: an update on Cotard’s syndrome 72
A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder 70
Earthquakes, economic crisis and, now, COVID-19: the cry of yell of Central Italy 67
The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review 63
Understanding the Complex of Suicide in Depression: from Research to Clinics 61
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy 61
S-Adenosyl-L-Methionine for Major Depressive Disorder” in the book entitled:” Melatonin, Neuroprotective Agents and Antidepressant Therapy 58
Second Generation Long-Acting Antipsychotics in the Treatment of Bipolar Disorder: A Clinical Viewpoint 48
Totale 6.161
Categoria #
all - tutte 19.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202144 0 0 0 0 0 0 0 0 0 0 0 44
2021/2022305 12 1 1 3 0 22 1 9 51 39 53 113
2022/2023370 54 21 24 9 59 49 3 36 61 23 17 14
2023/2024242 16 49 15 14 11 17 15 42 0 3 39 21
2024/20251.490 63 132 2 5 59 78 179 113 57 134 507 161
2025/20263.162 330 206 335 210 491 102 497 178 414 218 163 18
Totale 6.161